Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast Track designation to RNS60, its lead investigational therapy, for the treatment of acute ischemic stroke. This designation is intended to accelerate the development and review of RNS60, which could fill […]

Corsha Lands Cybernetix Ventures Investment to Set the Standard for Machine Identity in Robotics

Funding accelerates Corsha's machine identity platform protecting therapidly expanding robotics and AI ecosystem Corsha, the first and only Machine Identity Provider (mIDP) purpose-built to secure machine-to-machine (M2M) communication across operational systems and critical infrastructure, today announced an investment fromCybernetix Ventures, a leading early-stage VC firm at the forefront of robotics, automation, and physical AI. The

Wyndham Rewards Brings Vacation Vibes Back to Greensboro for 86th Annual Wyndham Championship

One million Wyndham Rewards points being given away every day as fan-favorites like Club Wyndham Beach and the Wyndham Rewards Earner Card Lounge make their much-anticipated return to Sedgefield Ever dreamed of turning your love of golf into a Wyndham Rewards million-point windfall? This week's Wyndham Championship, which tees off today at historic Sedgefield Country

SENIOR HELPERS NAMED ONE OF 2025’s BEST OF THE BEST FRANCHISES BY ENTREPRENEUR

Senior Helpers was recognized as one of the Best of the Best Franchises in 2025by Entrepreneur. The ranking, which is featured in the July/August issue of Entrepreneur magazine and on Entrepreneur.com, highlights the brands from Entrepreneur's 2025 Franchise 500 ranking that ranked at the top of their industry categories. Senior Helpers was ranked No. 1

Twin Vee PowerCats Co. to Host Q2 2025 Financial Results Call on August 7 at 12:00 pm Eastern

FORT PIERCE, FLORIDA / ACCESS Newswire / July 31, 2025 / Twin Vee PowerCats Co. (Nasdaq:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, will host a conference call and audio webcast on Thursday, August 7, 2025, at 12:00 p.m. (Eastern Time) to discuss and answer questions about the

Wheels Up Announces Date of Second Quarter 2025 Earnings Release

Wheels Up Experience Inc. (NYSE: UP) today announced that it will release its second quarter 2025 financial results on Thursday, August 7, 2025. https://mma.prnewswire.com/media/1776408/Wheels_Up_Logo.jpg Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading provider of on-demand private aviation in the U.S. with

CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Subway® Sends Fans to Their “Happy Place” with Immersive Restaurant Takeover and Interactive Fan Experience

On August 8, relive the most beloved moments from Happy Gilmore 2 as Subway and Netflix recreate the legendary golfer's dream world inside a Los Angeles restaurant Subway continues to immerse fans in the unforgettable world ofHappy Gilmore 2 with a new pop-up experience on August 8, transforming one of its Southern California restaurants into

Mezzion Pharmaceuticals Reaches Key Enrollment Milestone in World’s Largest Fontan Clinical Trial

Mezzion Pharmaceuticals, Inc. (Mezzion) announced that its confirmatory Phase 3 FUEL-2 study evaluating JURVIGO® (udenafil)1 in adolescents and young adults with Fontan circulation has surpassed a key enrollment milestone randomizing approximately 50% of the planned 400+ participants. https://mma.prnewswire.com/media/2741297/Mezzion_Pharmaceuticals_FUEL_2.jpg FUEL-2 is the largest randomized clinical trial ever conducted for the Fontan population, a group of patients

Scroll to Top